⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TXG News
10x Genomics, Inc. Class A Common Stock
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas
prnewswire.com
TXG
NVDA
Torex Gold Reports Q4 and Full-Year 2025 Results Ready to Announce with Confidence?
newsfilecorp.com
TXG
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
prnewswire.com
TXG
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
prnewswire.com
TXG
Genomic Testing Market Projected to Reach US$ 41.34 Billion by 2035, Supported by Rising Clinical Oncology Testing Volumes | Astute Analytica
globenewswire.com
NTRA
GH
EXAS
ILMN
PACB
TXG
TMO
TWST
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
prnewswire.com
TXG
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
prnewswire.com
TXG
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
prnewswire.com
TXG
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
prnewswire.com
TXG
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
businesswire.com
CDNA
TXG